On January 5, 2022 with a reversal of a “2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug” the floodgates opened for psychedelic drug development companies with Health Canada’s Special Access Program (SAP)
Big Surprise or No Surprise? Two Thirds of Doctors Surveyed Think Psilocybin has Mental Health Benefits
For those readers who are just tuning in to the psychedelic renaissance or for those who need a refresher it is not surprising news to seasoned psychonauts that these powerful medicines have curative properties.
I begin my second article of 2022 taking stock of who in the psychedelic world has already claimed their piece of history.
All this change in policy can’t seem to happen fast enough because there has been a shift toward recreational drug users taking microdoses of LSD and mushrooms to improve their wellbeing and mental health during the pandemic.
Measure 109 creates a license and regulatory framework for production of psilocybin and facilitation of psilocybin services for adults 21 years of age and older.
The goal of Measure 109 is to make psilocybin, the chemical compound found in magic mushrooms, legal for therapeutic use. This would make Oregon the first state in the country to do this.
The non-ordinary appears to be becoming the ordinary state of discourse in politics this week – in the space of two days Francis Collins, director of the National Institute of Health (NIH) copped to the fact that psychedelics…
MDMA. Most lay people have heard of it but by names like Ecstacy or Molly and not in connection to treating PTSD or trauma.
Can access to psychedelics and psychedelic therapy or access without the fear of criminal repercussions help folks overcome the stress, anxiety, depression and trauma associated with the pandemic?